SCD and fatty liver disease: Our results showing downregulations of ADRP on lipid droplets and SCD-1 by nor-NOHA in the liver indicate that arginase inhibition may exert its inhibitory effects on TG formation and development of fatty liver by modulating ADRP and SCD-1 through regulation of PPAR-γ2.